Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Cambridge, Massachusetts
- Most recent report
- 8-K, filed Sep 2, 2026
- Incorporated
- Delaware
- Filings on record
- 61 filings
- On EDGAR
- CIK 1657677
- Fiscal year ends
- December
- Filer status
- Emerging growth company
Financials 1
News 4
Prospectuses and Registrations 7
- S-8 Registration statement for an employee plan Jun 10, 2026
- 424B4 Final prospectus for an offering Jun 10, 2026
- FWP Free writing prospectus Jun 10, 2026
- S-1/A Registration statement for an offering, amended Jun 9, 2026
- S-1/A Registration statement for an offering, amended Jun 4, 2026
- S-1/A Registration statement for an offering, amended May 27, 2026
- S-1 Registration statement for an offering May 19, 2026
Ownership 8 of 37
- 4 Insider reported a trade Aug 25, 2026
- 3 Insider reported their initial holding Aug 25, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 14, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 6, 2026
- 4 Insider reported a trade Jul 22, 2026
- 4 Insider reported a trade Jun 29, 2026
- 3 Insider reported their initial holding Jun 29, 2026
- SCHEDULE 13D Large holder reported an active stake Jun 18, 2026
Other 8 of 12
- EFFECT Notice that a registration became effective Jun 9, 2026
- S-1MEF Jun 9, 2026
- CERT Exchange certified a listing Jun 9, 2026
- 8-A12B Registration of a security for exchange listing Jun 5, 2026
- DRS Draft registration statement, submitted confidentially Apr 2, 2026
- D Dec 2, 2022
- D Jan 5, 2021
- D/A Amended filing May 16, 2018
Everything here comes from Parabilis Medicines, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.